Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO
· Real-Time Price · USD
5.26
-0.23 (-4.19%)
At close: May 09, 2025, 3:59 PM
5.37
2.09%
After-hours: May 09, 2025, 05:37 PM EDT
-4.19% (1D)
| Bid | 5.26 |
| Market Cap | 256.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -63.73M |
| EPS (ttm) | -1.55 |
| PE Ratio (ttm) | -3.39 |
| Forward PE | -52.6 |
| Analyst | Buy |
| Ask | 5.61 |
| Volume | 1,058,523 |
| Avg. Volume (20D) | 1,306,624 |
| Open | 5.49 |
| Previous Close | 5.49 |
| Day's Range | 5.25 - 5.56 |
| 52-Week Range | 3.93 - 7.32 |
| Beta | 1.68 |
About ABEO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABEO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Abeona Therapeutics Inc. is scheduled to release its earnings on May 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+23.77%
Abeona Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 week ago
-0.93%
ABEO stock has given up its prior gain. Abeona Therapeutics shares were trading higher after the company announced FDA approval of ZEVASKYN for treating wounds in patients with recessive dystrophic epidermolysis bullosa.
